Markets:

Overview

News

Currencies

International

Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

2.110 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More ↗

August 03, 2023

A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...

Via Benzinga

Marijuana Stock Movers For July 31, 2023 ↗

July 31, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From July 28, 2023 ↗

July 28, 2023

Via Benzinga

Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial ↗

July 28, 2023

UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023:

Via Benzinga

Cannabis Stock Gainers And Losers From July 26, 2023 ↗

July 26, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From July 25, 2023 ↗

July 25, 2023

Via Benzinga

Cannabis Stock Movers For July 24, 2023 ↗

July 24, 2023

Via Benzinga

Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More ↗

July 24, 2023

Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal...

Via Benzinga

Enveric Unveils Positive Results From Preclinical Studies Supporting Metabolic Profile Of Its Psilocin Prodrug For Anxiety ↗

July 24, 2023

Enveric Biosciences (NASDAQ: ENVB) announced successful completion of preclinical absorption, distribution, metabolism, and excretion (ADME) and toxicology studies conforming to earlier positive...

Via Benzinga

Enveric Unveils Positive Results From Animal Studies Of Its Psilocin Prodrug For Anxiety ↗

July 17, 2023

Enveric Biosciences (NASDAQ: ENVB) announced positive results from pharmacokinetic animal studies demonstrating oral bioavailability, rapid onset of action and systemic clearance, and a more favorable...

Via Benzinga

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More ↗

July 04, 2023

World's Largest Psychedelics Conference Boasts 12K Attendees

Via Benzinga

Psychedelics Company Takes 'A Key Step' With New Formulation Of Its Psilocin Prodrug For Anxiety ↗

June 26, 2023

Enveric Biosciences (NASDAQ: ENVB) announced the development of an improved formulation of EB-373 designed to enhance the drug product’s scalability, stability, and delivery for ongoing preclinical...

Via Benzinga

Enveric Stock Trading Higher On Notice Of Allowance For Patent Application For Its Carboxylated Psilocybin Derivatives ↗

June 05, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent application pertaining to its EVM301 series of...

Via Benzinga

Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More ↗

May 31, 2023

Microdosing LSD For Major Depression Treatment Seeks Further Clinical Validation Via New Study Australian psychedelics company MindBio Therapeutics Corp. was granted approval by both the Ethics...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 30, 2023

Via Benzinga

Enveric Biosciences Rallies 300% As It Receives US Patents For Psychedelic Compounds ↗

May 27, 2023

Enveric Biosciences (ENVB) has recently received two patents for its novel psychedelic compounds, which are modeled from psilocybin mushrooms.

Via Talk Markets

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 25, 2023

Via Benzinga

Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 30, 2023

Gainers QualTek Services Inc. (NASDAQ: QTEK) shares jumped 127.2% to $0.1740 after dropping around 21% on Friday. Qualtek Services recently filed voluntarily petitions for Chapter 11 bankruptcy.

Via Benzinga

Why Nutanix Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket ↗

May 25, 2023

Gainers Nano Labs Ltd (NASDAQ: NA) shares rose 125% to $3.15 in pre-market trading.

Via Benzinga

Why Dollar Tree Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 25, 2023

Gainers Beamr Imaging Ltd. (NASDAQ: BMR) shares climbed 211.6% to $6.86 after NVIDIA announced the release of NVENC Video Codec SDK 12.1 showcasing the integration with Beamr CABR.

Via Benzinga

Crude Oil Rises 2%; Kohl's Reports Surprise Q1 Profit ↗

May 24, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 250 points on Wednesday. The Dow traded down 0.73% to 32,813.21 while the NASDAQ fell 0.77% to 12,463.32. The S&P...

Via Benzinga

Why Are Enveric Biosciences Shares Climbing? ↗

May 24, 2023

Enveric Biosciences, Inc. (NASDAQ: ENVB) shares nearly doubled Wednesday afternoon after the company received its second notice of allowance regarding its patent application related to its EVM201...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 24, 2023

Via Benzinga

Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

May 24, 2023

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.

Via Benzinga

Nasdaq Down 1%; US Crude Oil Inventories Decline Last Week ↗

May 24, 2023

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Wednesday. The Dow traded down 0.72% to 32,816.38 while the NASDAQ fell 1.12% to 12,419.97. The...

Via Benzinga

Dow Falls Over 100 Points; Analog Devices Posts Upbeat Q2 Earnings ↗

May 24, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.44% to 32,908.94 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 24, 2023

Via Benzinga

Enveric Stock Soars On Reception Of Notice Of Allowance For Patent Application For Its Psilocin Prodrug Designs ↗

May 24, 2023

Enveric Biosciences, Inc.

Via Benzinga

Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More ↗

May 23, 2023

Biotech Company Discovers What May Be The First New Compounds Of Psilocybin In History NY-based biotech platform Terran Biosciences announced the publication of an international PCT patent application...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

Headline News about Enveric Biosciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today